stockportfolio.pro
TMO vs UNH: Which Stock Is the Better Buy?
Thermo Fisher Scientific Inc. and UnitedHealth Group Incorporated side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — TMO vs UNH, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Thermo Fisher Scientific Inc. (TMO) | UnitedHealth Group Incorporated (UNH) | |
|---|---|---|
| Market cap | $197.9B | $387.0B |
| Revenue (latest FY) | $44.56B | $447.57B |
| Net income (latest FY) | $6.70B | $12.06B |
| Revenue growth (5y CAGR) | 6.7% | 11.7% |
| Net margin | 15.0% | 2.7% |
| Return on equity | 12.6% | 12.0% |
| P/E ratio | 29.2 | 32.1 |
| Dividend yield | 0.3% | 2.2% |
| Profitable years (of last 10) | 7 | 10 |
| Positive free cash flow | Yes | Yes |
See the full TMO vs UNH breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open TMO's full financials → Open UNH's full financials →Frequently asked questions
Which is bigger, TMO or UNH?
UnitedHealth Group Incorporated is larger by market capitalization — $387.0B versus $197.9B.
Which grows faster, TMO or UNH?
Over the last five fiscal years, UnitedHealth Group Incorporated grew revenue faster — 11.7%/yr versus 6.7%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
TMO fundamentals → · UNH fundamentals → · All 1,500+ companies → · Free screener →